Progyny, Inc. (PGNY)
NMS · Healthcare Plans
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Company overview
Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services, as well as pregnancy and postpartum, menopause and midlife, benefit and leave navigation, and parent and child wellbeing solutions. In addition, it provides assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Peers in Healthcare Plans
All in industry →UnitedHealth Group Incorporated
CVS Health Corporation
The Cigna Group
Elevance Health, Inc.
Humana Inc.
Centene Corporation
Molina Healthcare, Inc.
Alignment Healthcare, Inc.
Oscar Health, Inc.
Clover Health Investments, Corp.
Recent press releases
April 2026
PGNY Reports Revenue Growth and Client Expansion in Annual Filing
# 🧾 What This Document Is This is Progyny's Annual Report to Shareholders (ARS). Think of it as the company's "year-in-review" magazine, designed to give investors a comprehensive look at its performance, strategy, and outlook. While the actual text isn't provided here, an ARS typically includes a
Progyny Proposes Eliminating Supermajority Vote Requirements
# 📜 What This Document Is This is a **proxy statement** (DEF 14A) for Progyny, Inc. It's a formal document sent to shareholders before the annual meeting. Its job is to give you all the info you need to vote on company matters. Think of it as a detailed agenda and voter's guide. 👉 **In simple ter
SEC filings
All filings →Insider trades
All insider trades →Progyny, Inc. has no reported insider trades in the last 90 days.